These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30909027)

  • 21. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
    PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy.
    Lam J; DuBois JM; Rowley J; González-Otárula KA; Soucy JP; Massarweh G; Hall JA; Guiot MC; Rosa-Neto P; Kobayashi E
    Ann Neurol; 2019 Feb; 85(2):218-228. PubMed ID: 30597619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age and gender effects of
    Sakata M; Toyohara J; Ishibashi K; Wagatsuma K; Ishii K; Zhang MR; Ishiwata K
    Neurobiol Aging; 2017 Jul; 55():72-77. PubMed ID: 28431287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive quantification of metabotropic glutamate receptor type 1 with [¹¹C]ITDM: a small-animal PET study.
    Yamasaki T; Fujinaga M; Yui J; Ikoma Y; Hatori A; Xie L; Wakizaka H; Kumata K; Nengaki N; Kawamura K; Zhang MR
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):606-12. PubMed ID: 24398932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
    DuBois JM; Rousset OG; Rowley J; Porras-Betancourt M; Reader AJ; Labbe A; Massarweh G; Soucy JP; Rosa-Neto P; Kobayashi E
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):152-162. PubMed ID: 26290423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
    Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
    Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease.
    Terada T; Yokokura M; Obi T; Bunai T; Yoshikawa E; Ando I; Shimada H; Suhara T; Higuchi M; Ouchi Y
    J Neurol; 2019 Sep; 266(9):2186-2196. PubMed ID: 31139959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo imaging of the metabotropic glutamate receptor 1 (mGluR1) with positron emission tomography: recent advance and perspective.
    Li S; Huang Y
    Curr Med Chem; 2014; 21(1):113-23. PubMed ID: 23992339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate.
    Yamasaki T; Maeda J; Fujinaga M; Nagai Y; Hatori A; Yui J; Xie L; Nengaki N; Zhang MR
    Am J Nucl Med Mol Imaging; 2014; 4(3):260-9. PubMed ID: 24795840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington's Disease: a Longitudinal PET Study.
    Bertoglio D; Verhaeghe J; Korat Š; Miranda A; Cybulska K; Wyffels L; Stroobants S; Mrzljak L; Dominguez C; Skinbjerg M; Liu L; Munoz-Sanjuan I; Staelens S
    Mol Neurobiol; 2020 Apr; 57(4):2038-2047. PubMed ID: 31912442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition.
    Baghel V; Tripathi M; Parida G; Gupta R; Yadav S; Kumar P; Dey AB; Damle NA; Kumar R; Bal C
    Clin Nucl Med; 2019 Nov; 44(11):e597-e601. PubMed ID: 31584490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of inflammation in the medial temporal region in the development of agitation in Alzheimer's disease: an in vivo positron emission tomography study.
    Yasuno F; Kimura Y; Ogata A; Ikenuma H; Abe J; Minami H; Nihashi T; Yokoi K; Hattori S; Shimoda N; Watanabe A; Kasuga K; Ikeuchi T; Takeda A; Sakurai T; Ito K; Kato T
    Psychogeriatrics; 2023 Jan; 23(1):126-135. PubMed ID: 36403981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.